Your browser doesn't support javascript.
loading
A phase Ib study of everolimus combined with metformin for patients with advanced cancer.
Molenaar, Remco J; van de Venne, Tim; Weterman, Mariëtte J; Mathot, Ron A; Klümpen, Heinz-Josef; Richel, Dick J; Wilmink, Johanna W.
Afiliação
  • Molenaar RJ; Department of Medical Oncology, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • van de Venne T; Department of Medical Biology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • Weterman MJ; Cancer Center Amsterdam, Location Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • Mathot RA; Department of Medical Oncology, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • Klümpen HJ; Department of Medical Biology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • Richel DJ; Cancer Center Amsterdam, Location Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
  • Wilmink JW; Department of Medical Oncology, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105, AZ, Amsterdam, The Netherlands.
Invest New Drugs ; 36(1): 53-61, 2018 02.
Article em En | MEDLINE | ID: mdl-28616837

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Serina-Treonina Quinases TOR / Everolimo / Imunossupressores / Metformina / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Serina-Treonina Quinases TOR / Everolimo / Imunossupressores / Metformina / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda